Recent Guidelines on Anal Cancer Screening: A Systematic Review
- 28 February 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 29 (2) , 180-185
Abstract
Objectives: Reports have recently been published on the risk stratification of anal squamous cell carcinoma (SCC) in several populations and the benefits of treating precancerous anal lesions to reduce the risk of progression to anal SCC. These studies have led several societies to publish new recommendations for anal cancer screening. This study systematically reviews anal cancer screening recommendations across different societies and institutes published after the ANCHOR trial. Methods: The authors systematically reviewed society recommendations for anal cancer screening that have been published since July 2022. Results: This study included 6 publications: 3 societies made recommendations only for individuals living with HIV, and 3 made recommendations for other high-risk groups, such as women with vulvar cancer/high-grade squamous intraepithelial lesions (HSILs) and female transplant recipients. Four societies recommended anal cytology, with or without human papillomavirus (HPV) testing, as the first screening method. One society recommended anal cytology, HPV testing, or cotesting as possible options, while 1 suggested HPV type 16 testing. Only 1 society has made recommendations on screening discontinuation. High-resolution anoscopy was recommended during follow-ups for individuals with abnormal results, although the referral threshold varied between societies according to the screening method results. All societies that mentioned anal HSIL treatment recommended it. Four societies expanded their recommendations beyond screening and treatment to include smoking cessation and/or HPV vaccination. Conclusions: Currently, there are several recommendations for anal cancer screening that include target groups, screening methods, treatment, follow-up, and other anal SCC prevention methods.Keywords
This publication has 14 references indexed in Scilit:
- International Anal Neoplasia Society's consensus guidelines for anal cancer screeningInternational Journal of Cancer, 2024
- Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practiceTechniques in Coloproctology, 2024
- Impact of Human Papillomavirus Vaccine Against Anal Human Papillomavirus Infection, Anal Intraepithelial Neoplasia, and Recurrence of Anal Intraepithelial Neoplasia: A Systematic Review and Meta-analysisThe Journal of Infectious Diseases, 2023
- Anal High-risk Human Papillomavirus Infection, Squamous Intraepithelial Lesions, and Anal Cancer in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysisJournal of Crohn's and Colitis, 2023
- Global burden of HPV‐attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysisInternational Journal of Cancer, 2022
- A systematic review and meta‐analysis of cytology and HPV‐related biomarkers for anal cancer screening among different risk groupsInternational Journal of Cancer, 2022
- Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal CancerNew England Journal of Medicine, 2022
- Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studiesThe Lancet HIV, 2021
- A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scaleInternational Journal of Cancer, 2020
- Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2018